Factors influencing community pharmacists' enrollment in a state prescription monitoring program

Ulbrich, Timothy R.; Dula, Colleen A. Clark; Green, Christopher G.; Porter, Kyle; Bennett, Marialice S.

doi:10.1331/japha.2010.09089

Cited by 22 publications

(21 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[12,32,33] A recent report by the Prescription Drug Monitoring Program Center of Excellence at Brandeis estimated a median drug program registration rate of 35 percent among licensed prescribers who prescribed at least one controlled substance in the period 2010–12. [18] The limited effect of implementation that we found on overall opioid and pain medication prescribing can be partly explained by this low take-up.…”

Section: Discussionmentioning

confidence: 99%

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians

et al. 2016

View full text Add to dashboard Cite

State prescription drug monitoring programs are promising tools to rein in the epidemic of prescription opioid overdose. We used data from a national survey to assess the effects of the programs on the prescribing of opioid analgesics and other pain medication in ambulatory care settings at the point of care in twenty-four states from 2001 to 2010. We found that implementation of a prescription drug monitoring program was associated with more than a 30 percent reduction in the rate of prescribing of Schedule II opioids. This reduction was seen immediately following the launch of the program and was maintained in the second and third years afterward. Effects on overall opioid prescribing and prescribing of nonopioid analgesics were limited. Increased utilization of these programs and the adoption of new policies and practices governing their use may have contributed to sustained effectiveness. Future studies are needed to evaluate the comparative effectiveness of these policies.

show abstract

Section: Discussionmentioning

confidence: 99%

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The investigators concluded that 40% of the physicians who participated in the study had not heard of the PDMP. Of those that had, only 11% had requested information from the database, 60% Another survey study reviewed was one done by Ulbrich, Clark, Green, Porter, and Bennett (2010). This study surveyed pharmacists in Ohio in 2008 on factors influencing their enrollment in a state PDMP.…”

Section: Health Care Professionals' Perspectives On Pdmpsmentioning

confidence: 99%

Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research

Worley¹

2012

Issues in Mental Health Nursing

View full text Add to dashboard Cite

Prescription drug abuse is a major worldwide problem and its incidence is on the rise, resulting in a huge societal cost. Prescription drug monitoring programs (PDMPs) are electronic databases that collect data on controlled substances so that health care providers can access the data and deter abuse, doctor shopping, and diversion. Currently only a few countries, including the United States and France, have operational PDMPs. The purpose of this paper is to review the literature on prescription drug monitoring programs. There is a paucity of research articles in this area; only 11 articles were published on this topic and relevant in the last ten years. Four themes were identified, (1) the effect of PDMPs on prescribing practices and the effect of PDMPs on the public, (2) the effect of PDMPs on prescribing practices and multiple provider episodes, (3) the effect of PDMPs on prescribing practices and characteristics of patients, and (4) health care professionals' perspectives on PDMPs. Studies have shown that PDMPs decrease diversion and doctor shopping. Despite implementation of PDMPs, prescription drug rates for controlled substances and abuse rates have risen. There is an urgent need for understanding and research on this topic so that action can be taken.

show abstract

“…The overall response rate to the survey of 8.7% was low, however, surveys using email or other electronic means to recruit participants are reported to typically have low response rates 40. Surveys of pharmacists using similar methodology have reported response rates ranging from 1.4% to 63.1%, although most were in the range of 3.5-15% 41,42,43,44,45,46,47,48,49. From data provided in two surveys of Canadian pharmacists that used a variety of means of recruitment, including email, we estimated a response rate of approximately 4% for both surveys 41,42…”

Section: Discussionmentioning

confidence: 99%

Bioidentical hormone therapy: Nova Scotia pharmacists´ knowledge and beliefs

Whelan

Thebeau

Jurgens

et al. 2012

Pharmacy Practice (Internet)

View full text Add to dashboard Cite

ObjectiveTo investigate Nova Scotia (NS) pharmacists' knowledge and beliefs regarding the use of bioidentical hormones (BHs) for the management of menopause related symptoms.MethodsUsing Dillman’s tailored design methodology, an invitation to complete the web-based questionnaire was emailed to pharmacists in NS as part of the Dalhousie College of Pharmacy Continuing Pharmacy Education Department's (CPE) weekly email update. Data was analyzed using descriptive statistics.ResultsOf approximately 1300 e-mails sent, 113 pharmacists completed the questionnaire (response rate 8.7%). The majority of respondents (94%) knew that BHs were not free from adverse drug reactions. More than 50% were aware that conjugated equine estrogens and medroxyprogesterone acetate were not examples of BHs. For seven of eleven knowledge questions, 33-45% indicated that they did not know the answer. When asked about their beliefs regarding BHs, many believed that BHs were similar in efficacy (49%) or more effective (21%) than conventional hormone therapy (CHT) for vasomotor symptoms. Most respondents also believed that both BHs and CHT had similar safety profiles. Additionally, responding pharmacists indicated that more education would be helpful, especially in the area of safety and efficacy of BHTs compared to CHT.ConclusionsNS pharmacists knew BHs were not free of adverse effects, however knowledge was lacking in other areas. This may reflect the level of coverage of this topic in pharmacy school curriculums and in the pharmacy literature. Results indicate a need for additional education of NS pharmacists with respect to BHs, which could be accomplished through modification of undergraduate pharmacy programs and supplementary CPE.

show abstract

Factors influencing community pharmacists' enrollment in a state prescription monitoring program

Cited by 22 publications

References 4 publications

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians

Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research

Bioidentical hormone therapy: Nova Scotia pharmacists´ knowledge and beliefs

Contact Info

Product

Resources

About